Viking Therapeutics Comprehensive Income 2014-2024 | VKTX

Viking Therapeutics comprehensive income for the quarter ending June 30, 2024 was $-0.002B, a 118.46% increase year-over-year.

  • Viking Therapeutics comprehensive income for 2023 was $-0B, a 64.7% decline from 2022.
  • Viking Therapeutics comprehensive income for 2022 was $-0.001B, a 100.73% increase from 2021.
  • Viking Therapeutics comprehensive income for 2021 was $-0.001B, a 916.67% increase from 2020.

Viking Therapeutics Comprehensive Income 2014-2024 | VKTX

  • Viking Therapeutics comprehensive income for 2023 was $-0B, a 64.7% decline from 2022.
  • Viking Therapeutics comprehensive income for 2022 was $-0.001B, a 100.73% increase from 2021.
  • Viking Therapeutics comprehensive income for 2021 was $-0.001B, a 916.67% increase from 2020.